Literature DB >> 22990086

Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.

Richard Pitman1, David Fisman2, Gregory S Zaric3, Maarten Postma4, Mirjam Kretzschmar5, John Edmunds6, Marc Brisson7.   

Abstract

The transmissible nature of communicable diseases is what sets them apart from other diseases modeled by health economists. The probability of a susceptible individual becoming infected at any one point in time (the force of infection) is related to the number of infectious individuals in the population, will change over time, and will feed back into the future force of infection. These nonlinear interactions produce transmission dynamics that require specific consideration when modeling an intervention that has an impact on the transmission of a pathogen. Best practices for designing and building these models are set out in this paper.

Entities:  

Mesh：

Year:  2012        PMID： 22990086     DOI： 10.1177/0272989X12454578

Source DB:  PubMed          Journal:  Med Decis Making        ISSN： 0272-989X            Impact factor:   2.583


  42 in total

1.  A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease.

Authors:  Pooyan Kazemian; Sydney Costantini; Anne M Neilan; Stephen C Resch; Rochelle P Walensky; Milton C Weinstein; Kenneth A Freedberg
Journal:  J Biomed Inform       Date:  2020-06-08       Impact factor: 6.317

2.  Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios.

Authors:  Paul E Parham; Dyfrig A Hughes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-05       Impact factor: 6.237

3.  Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions.

Authors:  Jeanne Mandelblatt; Clyde Schechter; David Levy; Ann Zauber; Yaojen Chang; Ruth Etzioni
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

Review 4.  A systematic review of the quality of economic models comparing thrombosis inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Maximilian H M Hatz; Reiner Leidl; Nichola A Yates; Björn Stollenwerk
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

Review 5.  Cost-Effectiveness Analyses in Orthopaedic Surgery: Raising the Bar.

Authors:  Prashant V Rajan; Rameez A Qudsi; Lindsey L Wolf; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2017-07-05       Impact factor: 5.284

6.  Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative.

Authors:  Erika G Martin; Roderick H MacDonald; Daniel E Gordon; Carol-Ann Swain; Travis O'Donnell; John Helmeset; Adenantera Dwicaksono; James M Tesoriero
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

7.  Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy.

Authors:  Jennifer A Gilbert; Lauren Ancel Meyers; Alison P Galvani; Jeffrey P Townsend
Journal:  Epidemics       Date:  2013-11-19       Impact factor: 4.396

8.  Nonidentifiability in Model Calibration and Implications for Medical Decision Making.

Authors:  Fernando Alarid-Escudero; Richard F MacLehose; Yadira Peralta; Karen M Kuntz; Eva A Enns
Journal:  Med Decis Making       Date:  2018-10       Impact factor: 2.583

9.  GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.

Authors:  Jan L Brozek; Carlos Canelo-Aybar; Elie A Akl; James M Bowen; John Bucher; Weihsueh A Chiu; Mark Cronin; Benjamin Djulbegovic; Maicon Falavigna; Gordon H Guyatt; Ami A Gordon; Michele Hilton Boon; Raymond C W Hutubessy; Manuela A Joore; Vittal Katikireddi; Judy LaKind; Miranda Langendam; Veena Manja; Kristen Magnuson; Alexander G Mathioudakis; Joerg Meerpohl; Dominik Mertz; Roman Mezencev; Rebecca Morgan; Gian Paolo Morgano; Reem Mustafa; Martin O'Flaherty; Grace Patlewicz; John J Riva; Margarita Posso; Andrew Rooney; Paul M Schlosser; Lisa Schwartz; Ian Shemilt; Jean-Eric Tarride; Kristina A Thayer; Katya Tsaioun; Luke Vale; John Wambaugh; Jessica Wignall; Ashley Williams; Feng Xie; Yuan Zhang; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2020-09-24       Impact factor: 6.437

10.  Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation.

Authors:  Beate Jahn; Gaby Sroczynski; Martin Bicher; Claire Rippinger; Nikolai Mühlberger; Júlia Santamaria; Christoph Urach; Michael Schomaker; Igor Stojkov; Daniela Schmid; Günter Weiss; Ursula Wiedermann; Monika Redlberger-Fritz; Christiane Druml; Mirjam Kretzschmar; Maria Paulke-Korinek; Herwig Ostermann; Caroline Czasch; Gottfried Endel; Wolfgang Bock; Nikolas Popper; Uwe Siebert
Journal:  Vaccines (Basel)       Date:  2021-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.